Skip to main content
Dr. Robert L. Reid MD
Dr. Robert L.  Reid
Professor Emeritus
Contact Info

Research Interests:


Premenstrual syndrome



Other Interests:

Scuba diving, fishing, alpine skiing, gardening

Book Chapters

Reid RL. Endocrinology of premenstrual syndrome in Premenstrual Syndrome and Dysmenorrhea, Dawood MY, McGuire JL, Demers LM (eds), Urban and Schwarzenberg, Baltimore-Munich 1984 51-66.

Reid RL. Biology of the menstrual cycle in Proceedings, Fourth World Cong of Biological Psychiatry. Developments in Psychiatry, Volume 7, Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM (eds), Elsevier Science Publishers 1985, New York.

Reid RL. Mood and behavioral disorders during the menstrual cycle in Proceedings of the Eighth International Congress of Psychosomatic Obstetrics and Gynecology, Dennerstein L, Fraser I (eds), Elsevier Science Publishers, Amsterdam, 1986 120-129.

Reid RL. Pathophysiology and treatment of premenstrual syndrome in Ethical and Legal Implications of the Biobehavioural Sciences: Premenstrual Syndrome. Carter BF, Ginsburg BC (eds), Plenum Press, New York, 1987 329-350.

Reid RL, Yen SSC. LHRH agonists and antagonists: Therapeutic possibilities for premenstrual syndrome in LHRH and Its Analogues: Contraceptive and Therapeutic Applications, Part 2. Vickery BH, Nestor JJ (eds), MTP Press, Lancaster, England, 1987 279-292.

Reid RL. Endogenous opiate peptides and premenstrual syndrome in Seminars in Reproductive Endocrinology. Lobo RA (Ed), Thieme-Stratton Inc., New York, New York, May 1987 5(2) 191-197.

Reid RL. Premenstrual syndrome: Medical hypotheses in Premenstrual Syndrome. Keye WR (ed), W.B. Saunders Co., Philadelphia, 1988.

Reid RL. The premenstrual syndrome – A product of the woman’s movement or a real entity? Chapter 6 in Controversies in Reproductive Endocrinology & Infertility. Soules MR (ed), Elsevier Publishing Co., New York, New York, 1989 79-93.

Reid RL, Fretts RL. Premenstrual syndrome in Principles and Practice of Endocrinology and Metabolism. Becker KL (ed), J.B. Lippincott Co. Philadelphia 1989, Second Edition 1995, Third Edition 2000, Fourth Edition CD Version 2002.

Reid RL. Premenstrual syndrome: Theories of pathophysiology in Premenstrual, Postpartum and Menopausal Mood Disorders. Demers LM, McGuire JL, Phillips A, Rubinow DR (eds), Urban & Schwarzenberg, Baltimore, 1989 1-18.

Reid RL. Epidemiology, clinical phenomenology and etiology of LLPDD: Neuroendocrine factors in Proceedings of Late Luteal Phase Dysphoric Disorder Workshop. Am Psychiat Press 1990.

Yamamora D, Reid RL. Psychological stress and the reproductive system in Seminars in Reproductive Endocrinology. Speroff L (ed), Thieme Medical Publication, 1990 65-73.

Reid RL. Guest editor: Interactions between lifestyles, environment, and the reproductive system in Seminars in Reproductive Endocrinology. February 1990 8(1).

Carr JS, Reid RL. Ovulation induction with gonadotropin releasing hormone in Seminars in Reproductive Endocrinology. Ho Yuen B (Ed), Thieme Medical Publishers 1990 8(3): 174-185.

Reid RL, Lorrain J, Casper RF. The effect of progestins on compliance in The Canadian Conference on the Use of Progestins in Menopause. Journal SOGC 1991 13(5).

Maddocks SE, Reid RL. Negative life stress & PMS: Some preliminary findings in Menstrual Health and Women’s Lives. Dan AJ, Lewis LL (eds), Univ Ill Press, 1992 38-51.

Reid RL. Induction of Ovulation in Proc 13th World Congress of Obstetrics and Gynecology, FIGO, Singapore, September 1992, Volume 1, Fertility, Sterility and Contraception. Parthenon Publish, Park Ridge, New Jersey.

Reid RL. Amenorrhea in Textbook of Gynecology. Copeland L, Jarrell J, McGregor J (eds), WB Saunders Co., Philadelphia, 1993 365-390 (Second Edition 1999).

Jamieson MA, Reid RL. Compliance with menopausal hormone replacement therapy in Modern Management and Treatment of Menopause and Osteoporosis. Lorrain J (ed), Les Presses de l’Université de Montréal, Montréal, Québec, 1993 622-627. (Second Edition 1995).

Reid RL. Psychological aspects of menstruation in Textbook of Reproductive Medicine. Carr BR, Blackwell RE (eds), Appleton & Lange, Norwalk, Connecticut, 1993 645. (Second Edition 1998)

Reid RL. Chairperson and Editor 1992-1993. Ethical considerations of the new reproductive technologies:

Part I                     Journal SOGC 14(4): 121-128
Part II                    Journal SOGC 14(5): 84-90
Part III                   Journal SOGC 14(6): 84-86
Part IV                  Journal SOGC 14(7): 100-103
Part V                   Journal SOGC 14(9): 97-102
Part VI                  Journal SOGC 14(10): 91-93
Part VII                 Journal SOGC 15(2): 201-206
Part VIII                Journal SOGC 15(3): 316-323
Part IX                  Journal SOGC 15(4): 487-490
Part X                   Journal SOGC 15(5): 643-645
Part XI                  Journal SOGC 15(6): 761-764

Reid RL, Houlden R. Disorders of the pituitary thyrotroph in Reproductive Endocrinology, Surgery, and Technology, Adashi EY, Rock JA, Rosenwaks Z (eds.) Lippincott-Raven, New York 1996 2(67): 1325-1338.

Reid RL. Ovulation: Does it cause psychopathology? In Gonadal Hormones, Sex, and Behaviour, Halbreich (ed), in the book series Hormones, Brain, and Neuropsychopharmacology 1996.

Pottier RH, Kennedy JC, Reid RL. New directions in ALA-PDT. In Photochemotherapy: Photodynamic Therapy and Other Modalities III. Berg K, Ehrenberg B, Malik Z, Moan J (eds) SPIE 1997 3191:200-209.

Working Group, SOGC Clinical Practice Guidelines, Hormone Replacement Therapy: An Update. Journal SOGC 1998.

Participant and Co-author: The Canadian Consensus Conference on Contraception. 1998 Journal SOGC 20(5); Journal SOGC 20(6); Journal SOGC 20(7); Journal SOGC 20(8).

Participant and Co-author: Canadian Menopause Consensus Document. 1998 Journal SOGC 20(13); Journal SOGC 20(14).

Wyss P, Steiner RA, Gannon MJ, Reid RL, Tadir Y. Introduction to Photomedicine in Gynecology and Reproduction. Wyss P, Tadir Y, Tromberg BJ, Haller U (eds) Karger, Basal, Switzerland 2000;176-182.

Van Vugt DA, Krzemien A, Foster W, Lundahl S, Marcus S, Reid RL. Photodynamic endometrial ablation in non-human primates. Photomedicine in Gynecology and Reproduction. Wyss P, Tadir Y, Tromberg BJ, Haller U (eds) Karger, Basal, Switzerland 2000;213-218.

Reid RL, Yang JZ, Krzemien A, Melchior MF, Van Dijk JP, Hahn PM, Van Vugt DA, Greer PA, Dickson E, Pottier RH. Potential application of PDT for treatment of endometriosis and ectopic pregnancy: animal models. Photomedicine in Gynecology and Reproduction, Wyss P, Tadir Y, Tromberg BJ, Haller U (eds) Karger, Basal, Switzerland 2000; 302-307.

Reid RL. Current Issues in Premenstrual Syndrome in Contemporary Therapy in Obstetrics & Gynecology. Ransom SB, Dombrowski MP, Evand MI, Ginsburg K (eds) W.B. Saunders Co. 2000.

Reid RL. Premenstrual Syndrome in Danforth’s Obstetrics and Gynecology. 9th Edition. R. Gibbs, A Haney, B Karlan, JR Scott (eds) Elsevier, Philadelphia, 2002. Revised chapter in 10th Edition 2008

Reid RL. (March 25, 2002) Chapter 10. Premenstrual Syndrome. In: Female Reproductive Endocrinology. Rebar RW (editor). an on-line endocrine text edited by L DeGroot [Internet]   last revised November 2014

Reid RL and Case A. Premenstrual Syndrome and menstrual related disorders in T Falcone and WW Hurd eds: Clinical Reproductive Medicine and Surgery, Elsevier Inc Philadelphia 2007

Reid RL, Menopause in J SanFillippo, E Bieber, I Horowitz eds; Clinical Gynecology. Elsevier Inc., Philadelphia, 2006, Second Edition 2014

Reid RL, Mills C. Hormone therapy and Cancer. Canadian Consensus Document on Menopause and Osteoporosis: 2006 Update. JOGC 2006; Suppl 171: S1-S112

Reid RL, VanVugt DA. Chapter 8: Physiology of the Menstrual Cycle in PMS O’Brien, AJ Rapkin, & PJ Schmidt Eds; Premenstrual Dysphoric Disorder, Informa Healthcare Medical Publishers Oxfordshire UK 2007

Reid RL. Research in residency, other health training and practice: Why? When? and How? “The Research Guide: A Primer for Residents, Other Health Trainees and Practitioners”. Ottawa: Royal College of Physicians and surgeons of Canada; 2011,Chapter 2, pp11-14

Reid RL. Responsibility and integrity: Disseminating research findings to the public. “The Research Guide: A Primer for Residents, Other Health Trainees and Practitioners: Ottawa: Royal College of Physicians and surgeons of Canada; 2011,Chapter 31, pp. 277-285

Martin V, Reid RL. Amenorrhea in eds ET Bope, RD Kellerman; Conn’s Current Therapy 2014; Saunders/Elsevier, Philadelphia 979-981 Seventh Edition, 2014

VanVugt DA, Reid RL. ‘Neuroimaging menstrual cycle associated changes in appetite’ in Handbook of diet and nutrition in the menstrual cycle, periconception and fertility January 2014

Review Articles

Reid RL, Yen SSC. The premenstrual syndrome. Am J Obstet Gynecol 1981 139(1): 85-104.

Reid RL. Premenstrual syndrome: A therapeutic enigma. Drug Therapy 1982 12:65-75.

Reid RL, Yen SSC. Premenstrual syndrome. Clin Obstet Gynecol 1983 26(3) 710-718.

Reid RL. Premenstrual syndrome: New concepts. Proc of a Seminar by Canadian Community for Fertility Research. Val David, Quebec, 1984, Publication of Health and Welfare Canada.

Reid RL. Premenstrual syndrome. Curr Probl Obstet Gynecol 1985; VIII (2).

Reid RL, Quigley ME, Yen SSC. Pituitary apoplexy: A review. Arch Neurol 1985 42(7): 712-719.

Reid RL. PMS: Fad? Fact? Or Fallacy? SOGC Bulletin, Interview on an Issue 1986 9(2): 27-32.

Reid RL. Premenstrual syndrome: A time for introspection. Am J Obstet Gynecol 1986; 155(5): 921-926.

Reid RL, Van Vugt DA. Neuroendocrinology of the menstrual cycle: An overview. Contemp Ob/Gyn 1987 30 (3): 147-155.

Thomas RP, Reid RL. Thyroid disease and reproductive dysfunction. Obstet and Gynecol 1987 70(5): 789-798.

Thomas RP, Reid RL. Thyroid disease and pregnancy: Effects on the mother, fetus and newborn. Family Practice Recertification.1988; 10(10): 45-64

Kirkham C, Reid RL. Relative risk or oral contraceptive usage. Fertility and Sterility April 1987 47(4): 557-558, and Letter to Editor, Fertil Steril 1987 48(6): 1073-1074.

Reid RL, Maddocks S. Premenstrual syndrome and the active woman. Contemp Ob Gyn 1987 29:41-54.

Reid RL, Van Vugt DA. Weight related changes in reproductive function. Fertil Steril 1987 48(6): 905-913.

Reid RL. Premenstrual syndrome. Am Assoc Clin Chem 1987 5 (12): 1-12.

Reid RL. Premenstrual syndrome. Med North Am 1987 14:2675-2685.

Reid RL. Management of the “normal” infertile couple. SOGC Bulletin 1987, Interview on an Issue 9 (1): 23-27.

Reid RL, Fretts R, Van Vugt DA. The theory and practice of ovulation induction with gonadotropin releasing hormone. Am J Obstet Gynecol 1988 158(1): 176-185.

Reid RL, Van Vugt DA. Hair loss in women. Obstet Gynecol Survey 1988 43(3) 135-141.

Reid RL, Thomas R. Thyroid disease and reproductive dysfunction in non-gravid females. Fam Prac Recertification 1988 10(9): 45-53.

Reid RL, Thomas R. Thyroid disease and pregnancy: Effects on the mother, fetus, and newborn. Fam Prac Recertification 1988 10(10) 45-64.

Reid RL. Menopause, Part 1: Hormonal replacement. SOGC Bulletin, Special Feature, 1988.

Reid RL. Progestins in menopausal hormone replacement therapy: Good news and bad news! JSOGC 1990 31-35.

Reid RL, Lorrain J, Casper RF. The effect of progestins on compliance. JSOGC 1991 13:27-32

Reid RL. Use of gonadotropin releasing hormone agonists for menstrual cycle related disorders. JSOGC 1992 14:59-65.

Reid RL, Robinson GE. What to do about premenstrual syndrome? Patient Care 1992 3(10).

Reid RL. Optimizing regimens of hormone replacement therapy. JSOGC 1993 15:995-1000.

Reid RL. Which contraceptive methods are suitable for the older woman? JSOGC 1993 15:933-944.

Michael E, Reid RL. Non-contraceptive benefits of oral contraceptives in the perimenopausal woman. JSOGC 1994 16(5)(Suppl): 1-7.

Reid RL (Editor). Journeys, A four part series on menopause for physicians. Kommunicom Publication, 1996 1-23.

Kwon JS, Reid RL. Dysmenorrhea. JSOGC 1997 19(9): 955-962.

Case AM, Reid RL. Effects of the menstrual cycle on medical conditions. Arch Intern Med 1998 158(13): 1405-1412.

Reid RL. Endometriosis: Unraveling the enigma. Patient Care 1999 10(7): 53-56.

Case AM, Reid RL, Menstrual cycle effects of common medical conditions Comprehensive Therapy 2001; 27(1):65-71

Journal Articles

Reid RL, Pancham SR, Kean WF, Ford PM. Maternal and neonatal implications of congenital complete heart block in the fetus. Obstet Gynecol 1979; 54(4): 470-474.

Reid RL, Ling N, Yen SSC. ą-Melanocyte Stimulating hormone induces gonadotropin release. JCEM 1981 52(1): 159-161.

Reid RL, Hoff JD, Yen SCC, Li CH. Effects of exogenous βh-endorphin on pituitary hormone secretion and its disappearance rate in normal human subjects. JCEM 1981 52(6): 1179-1184.

Reid RL, Yen SSC. β-Endorphin stimulates the secretion of insulin and glucagons in humans. JCEM 1981 52(3): 592-594

Reid RL, Leopold GR, Yen SSC. Induction of ovulation and pregnancy by pulsatile luteinizing hormone releasing factor: Dosage and modes of delivery. Fertil Steril 1981 36(5): 553-559.

Reid RL, Artman J, Fisher DA, Yen SSC. Effects of synthetic β-endorphin on release of neurohypophyseal hormones. The Lancet 1981 2(8256): 1169-1170.

Reid RL, Yen SSC. Effect of β-endorphin on arginine induced release of growth hormone and prolactin release. Life Sci 1981; 29(25): 2641-2647.

Reid RL. Endogenous opioid activity and the premenstrual syndrome. Lancet 1983; 2(8353): 786.

Millar DS, Reid RL, Cetel NS, Rebar RW, Yen SSC. Pulsatile administration of low doses of gonadotropin releasing hormone for the induction of ovulation and pregnancy in women with hypothalamic amenorrhea. JAMA 1983 250:2937-2941.

Reid RL, Quigley ME, Yen SSC. The disappearance of opioidergic regulation of gonadotropin secretion in postmenopausal women. JCEM 1983 57(6): 1107-1110.

Reid RL, Sauerbrei E. Evaluation of techniques for induction of ovulation in outpatients employing pulsatile gonadotropin releasing hormone. AJOG 1984; 148(5): 648-656.

Reid RL, Sheehan K, Ling N, Yen SSC. Gonadotropin releasing activity of alpha-melanocyte-stimulating hormone in normal subjects and in subjects with hypothalamic pituitary dysfunction. JCEM; 1984 58(5): 773-777.

Cumming DC, Reid RL, Quigley ME, Rebar RW, Yen SSC. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin Endocrinol (Oxf) 1984 20(6): 643-648.

Reid RL, Sandler JA, Yen SSC, Beta-endorphin stimulates the secretion of insulin and glucagon in diabetes mellitus. Metabolism. 1984 33(3): 197-199.

Yen SSC, Quigley ME, Reid RL, Ropert MD, Cetel NS. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion. AJOG 1985; 152(4): 485-493.

Maddocks SE, Hahn P, Moller F, Reid RL. A double blind, placebo controlled, trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. AJOG 1986; 154 (3): 573-581. (Correspondence: AJOG 156 (6): 1555-1556, 1987).

Reid RL, Greenway-Coates A, Hahn P. Oral glucose tolerance during the menstrual cycle in normal women and women with alleged premenstrual “hypoglycemic” attacks: Effects of naloxone. JCEM 1986; 62(6): 1167-1172.

Nguyen KT, Reid RL, Sauerbrei E. Antenatal sonographic detection of a fetal ovarian theca lutein cyst: A clue to maternal diabetes mellitus. J Ultrasound Med 1986; 5(11): 665-667.

Reid RL. Neuropeptides and PMS. Fertil Steril 1986; 46(4): 738-40.

Casper RF, Graves G, Reid RL. Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 1987; 47(2): 341-344.

Hahn PM, Van Vugt DA, Reid RL. The stability of synthetic gonadotropin releasing hormone in solution. Fertil Steril 1987; 48(1): 155-158.

Mais V, Cetel NS, Muse KN, Quigley ME, Reid RL, Yen SSC. Hormonal dynamics during luteal-follicular transition. JCEM 1987; 64(6): 1109-1114.

Mauri M, Reid RL, MacLean AW. Sleep in the premenstrual phase: A self report study of premenstrual syndrome patients and normal controls. Acta Psychiat Scand. 1988; 78(1): 82-86.

Van Vugt DA, Webb MY, Reid RL. Comparison of the duration of action on nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey. Neuroendocrinol 1989; 49(3): 275-280.

Van Vugt DA, Webb MY, Reid RL. Naloxone antagonism of corticotrophin releasing hormone stimulation of prolactin secretion the rhesus monkeys. JCEM 1989; 68(6): 1060-1066.

Pauli BD, Reid RL, Munt PQ, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatics and normal subjects. Am Rev Resp Dis 1989; 140(2): 358-62.

Van Vugt DA, Baby N, Stewart M, Reid RL. The paradoxical stimulatory effect of morphine on LH secretion is dose-dependent and naloxone reversible. Neuroendocrinol 1989; 50(1): 109-116.

Fisch P, Casper RF, Brown SE, Wrixon W, Collins JA, Reid RL, Simpson C. Unexplained infertility: Evaluation of treatment with clomiphene citrate and human chorionic gonadotropin. Fert Steril 1989; 51(5): 828-833.

Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. AJOG 1990; 162: (1): 99-105.

Chamberlain S, Casson P, Hahn PM, Reid RL. Effect of menstrual cycle phase and oral contraceptive usage on serum lithium levels after a loading dose of lithium in normal women. Am J Psychiat 1990; 147(7): 907-909.

Caughey SC, Margesson LJ, Reid RL. Erythema multiform with ulcerative stomatitis at menstruation. Canadian J Obstet Gynecol 1990; 112-113.

Kirkham C, Reid RL, Hahn PM, Van Vugt DA, Carmichael JA. A randomized, double blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy. Obstet Gynecol 1991; 78(1): 93-97.

Reid RL. Premenstrual syndrome. N Engl J Med 1991 324(17):1208-1210.

Monga M, Reid RL. Superfoetation in the human: A Case Report. JSOGC 1992; (14) 81-84.

Van Vugt DA, Heisler L, Reid RL. Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates. JCEM 1992; 74(6): 1312-1319.

Heisler L, Pallotta C, Reid RL, Van Vugt DA. Hypoglycemia induced inhibition of luteinizing hormone secretion in the rhesus monkey is not mediated by endogenous opiate peptides. JCEM 1993; 76(5): 1280-1285.

Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium. Photochem Photobiol 1993 57(5): 803-807.

Yang JZ, Van Vugt DA, Kennedy JC, Reid RL. Evidence of lasting functional destruction of the rat endometrium following 5-amniolevulinic acid induced photodynamic ablation: prevention of implantation. AJOG 1993; 168(3 Pt 1): 995-1001.

Jamieson MA, Reid RL. Factors perceived by community physicians to affect prescribing patterns and patients’ compliance with hormone replacement therapy. JSOGC 1993; 15(5): 622-627.

Murray SC, Reid RL. Management of menorrhagia in the obese patient. Cdn J Obstet Gynecol & Women’s Health Care 1993; 5(2): 415-418.

Davies GAL, Reid RL. A comparison of laparoscopy & laparotomy for oophorectomy. JSOGC 1993; 15(10): 1174-1178.

Reid RL, Lie K, Spence JE, Tulandi T, Yuzpe A. Clinical evaluation of the efficacy of heparin-saturated Interceed for prevention of adhesion reformation in the pelvic sidewall of the human. Prog Clin Biol Res 1993 381:261-264.

Heisler L, Tumber AJ, Reid RL, Van Vugt DA. Vasopressin mediates hypoglycemia-induced inhibition of luteinizing hormone secretion in the ovariectomized rhesus monkey. Neuroendocrinol 1994; 60(3): 297-304.

Rittmaster RS, Collins JA, Daya D, Gagnon C, Graves GR, Greenblatt E, Jarrell JJ, Leader A, Martin R, Reid RL, Zhang X. Response to the report of the royal commission on new reproductive technologies: A summary. CMAJ 1994; 151(10): 1425-1430.

Yang JZ, Van Vugt DA, Melchior MF, Hahn PM, Reid RL. Photodynamic ablation of early pregnancy in the rat with 5-amniolevulinic acid: A potential new therapy for tubal ectopic pregnancy in the human. Fert Steril 1994; 62:1060-1065.

Reid RL. Should women give birth after menopause? Fam Prac 1994 6(29): 14.

Hahn PM, Van Vugt DA, Reid RL. A randomized placebo controlled clinical trial of Danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinol 1995; 20(2): 193-209.

Yang JZ, Greer PA, Van Vugt DA, Reid RL. Treatment with 5-aminolevulinic acid and photo activating light causes destruction of preimplantation mouse embryos. Fertil Steril 1995; 63(5): 1088-1093.

Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid RL, Grover D, Streiner D, for the Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group: Fluoxetine in the treatment of premenstrual dysphoria. NEJM 1995 332(23): 1529-1534.

Yang JZ, Van Dijk-Smith JP, VanVugt DA, Kennedy JC, Reid RL. Fluorescence and photosensitization of experimental endometriosis in the rat after systemic 5-aminolevulinic acid administration: A potential new approach to the diagnosis and treatment of endometriosis. AJOG 1996; 174(1 Pt 1): 154-160.

Yang JZ, Van Vugt DA, Roy BN, Kennedy JC, Foster WG, Reid RL. Intrauterine 5-amniolevulinic acid induces selective endometrial fluorescence in the rhesus and cynomolgus monkeys. J Soc Gynecol Investig 1996; 3(3): 152-157.

Reid RL, Hahn PM, Spence JEH, Tulandi T, Yuzpe AA, Wiseman DM. A randomized clinical trial of oxidized regenerated cellulose adhesion barrier (Interceed TC7) alone or in combination with heparin. Fertil Steril 1997; 67(1): 23-29.

Roy BN, Van Vugt DA, Weagle GE, Pottier RH, Reid RL. Effect of 5-aminolevulinic acid dose and estrogen on protoporphyrin IX concentrations in the rat uterus. J Soc Gynecol Invest 1997; 4(1): 40-46.

Van Vugt DA, Piercy J, Farley AE, Reid RL, Rivest S. Luteinizing hormone secretion and corticotropin-releasing factor gene expression in the paraventricular nucleus of rhesus monkeys following cortisol synthesis inhibition. Endocrinol 1997; 138(6): 2249-2258.

Potvin W, Reid RL: Vaginal placement of oral contraceptive pills. JSOGC 1997; 19(5): 523-526.

Steiner M, Lamot J, Steinberg W, Stewart D, Reid RL, Streiner D: Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria. Obstet Gynecol 1997; 90(4) Part I: 590-595.

Roy BN, Van Vugt DA, Reid RL. Photodynamic therapy in gynecology: Bringing scientific discovery to the clinical arena. JSOGC 1997; 19(7): 709-719.

Van Vugt DA, Washburn D, Farley AE, Reid RL. Hypoglycemia-induced inhibition of LH and stimulation of ACTH secretion in the rhesus monkey is blocked by alprazolam. Neuroendocrinol 1997; 65(5): 344-352.

Casper RF, Dodin S, Reid RL, and study investigators. The effect of 20μg ethinyl estradiol and 1mg norethindrone acetate (Minestrin™), a low dose oral contraceptive on vaginal bleeding patterns, hot flashes and quality of life in symptomatic perimenopausal women. Menopause 1997; 4(3): 139-147.

Roy BN, Van Vugt DA, Weagle G, Pottier R, Reid RL. Effect of continuous and multiple doses of 5-amniolevulinic acid on protoporphyrin IX concentrations in the rat uterus. J Photochem Photobiol 1997; 41(1-2): 122-127.

Reid RL. More on breast cancer guidelines. CMAJ 1998; 158(11): 1426; discussion 1429-30.

Jamieson MA, Walker M, Daicar AO, Reid RL. False allegation of pregnancy resulting from incestuous rape and physician misconduct: proof positive. J Paediat Adolesc Gynaecol 1998; 11(4): 181-184.

Hahn PM, Wong J, Reid RL. Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril 1998; 70(5): 913-918.

Case AM, Reid RL. Diagnosis of menopause in perimenopausal women taking oral contraceptives. JSOGC 1998; 20(12): 1159-1162.

Steiner M, Streiner D, Steinberg S, Stewart D, Carter D, Berger C, Reid RL, Gorver D. The measurement of premenstrual mood symptoms. J Affect Dis 1999; 53(3): 269-273.

Reid RL, Van Vugt DA, Hahn PM. Development of a national course on research methodology for Canadian residents in obstetrics and gynecology. Obstet Gynecol 1999; 93(2): 308-311.

Winsor SHM, Fisher S, Hahn PM, Reid RL. Retrospective evaluation of the long-term outcomes following medical management of menorrhagia in ovulatory women. JSOGC 1999; 21(2): 155-163.

Roy BN, Reid RL, Van Vugt DA. Effects of estrogen and progesterone on corticotrophin releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinol 1999; 140(5): 2191-2198.

Winsor SHM, Case AM, Kwon J, Reid RL. Touch-pad technology: Immediate feed back for resident educators in teenage reproductive health. Obstet Gynecol 1999; 93(5): 790-794.

Krzemien A, Van Vugt DA, Pottier R, Dickson E, Reid RL. Evaluation of novel non-laser light source for endometrial ablation using 5-amniolevulinic acid. Lasers Surg Med 1999; 25:315-322.

Tessier J, Reid RL. Polycystic ovarian syndrome: Gynecologic and metabolic implications. JSOGC 1999; 21 (13): 1222-1229.

Lee JY, Hahn PM, Van Dijk JP, Reid RL. Treatment of menorrhagia with tranexamic acid. JSOGC 2000; 22(10): 794-798.

Van Vugt DA, Krzeimen A, Roy BN, Foster W, Fletcher WA, Lundahl LS, Marcus SL, Reid RL. Photodynamic endometrial ablation in the non-human primate. J Soc Gynecol Invest 2000; 7(2): 125-130.

Reid RL. Progestins in hormone replacement therapy: Impact on endometrial and breast cancer. JSOGC 2000; 22(9): 677-681.

Case AM, Reid RL. Menstrual cycle effects on common medical conditions. Comprehensive Therapy 2001; 27(1): 65-71.

Steiner M, Romano SJ, Babcock S, Dillon J, Shuler C, Berger C, Carter D, Reid RL, Stewart D, Steinberg S, Judge R. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. Br J Obstet Gynecol 2001; 108(5): 462-468.

Tessier J, Hahn P, Reid RL. Media training for residents in Obstetrics and Gynecology: Improving communication skills and advocacy for women’s health. JSOGC 2001; 23(6): 495-500.

Shridhar S, Farley A, Reid RL, Foster WGeffect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on corticotrophin-releasing hormone, arginine vasopressin, and pro-opiomelanocortin mRNA levels in the hypothalamus of the cynomolgus monkey. Toxicological Sciences 2001; 63:181-188.

Reid RL. Hirsutism: A growing concern about over – reliance on laboratory evaluation. J Pediatr Adolesc Gynecol 2001; 14:95-97.

Reid RL. Hormone replacement therapy and breast cancer. (Letter) JOGC 2002; 24(1): 11-14.

Reid RL. Editorial on Venlafaxine was more effective than placebo for the treatment of premenstrual dysphoric disorder. Evidence-Based Obstet Gynecol 2002; 4(1): 30-31.

Reid RL. Update on Contraception Awareness Project. Canadian Family Physician 2002; 48:1090-1091, 1097-1098.

Krzemien A, Van Vugt DA, Reid RL. Effectiveness of photodynamic therapy for destruction of endometrial explants in a rat endometriosis model. Fertil Steril 2002; 78(1): 169-175.

Abramson B, Derzko C, Lalonde A, Reid RL, Turek M, Wielgosz A. Hormone replacement therapy and cardiovascular disease. JSOGC 2002; 24(7): 577-579.

Abramson B, Derzko C, Lalonde A, Reid RL, Turek M, Wielgosz A. Hormone replacement therapy and cardiovascular disease: A joint statement. Can J Cardiol 2002:18 (7): 723-724.

Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor, letrozole, on ovulatory function in normal women. Fertil Steril 2002; 78(2): 280-285.

Reid RL. Translating the latest scientific advances into clinical practice – the Women’s Health Initiative Study. (Editorial) Evidence-based Obstet Gynecol 2002; 4 (3): 110-111.

Blake JM, Collins JA, Reid RL, Fedorkow DM, Lalonde AB, Christilaw J, Fortier M, Fortin C, Jolly EE, Lemay A, O’Grady T, Smith TE, Cooper J, Maxted JM, O’Grady K, Turek MA. The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women. JOGC 2002: 24(10); 783-790, 793-802.

Reid RL. Translating the latest scientific advances into clinical practice. (Editorial) JOGC 2002; 24(10): 771-4, 776-779.

Oakes J, Lillicrap D, Hahn PM, Reid RL. A national survey of gynecologist’s recommendations to oral contraceptive users about contraception in the perioperative period. AJOG 2002; 187:1539-1543

Rowe T, Poulin Y, Reid RL. Diane 35 – Is it an oral contraceptive? JOGC 2002; 24 (10) (Suppl): 1-4

Steiner M, Brown E, Trzepacz P, Dillon J, Berger C, Carter D, Reid RL, Stewart D. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder. Arch Womens Ment Health 2003; 6:71-77.

Reid RL. Hormone Therapy: The Women’s Health Initiative has caused confusion and concern. Fertil Steril 2003; 80 (3):491-493.

Gaudet L, Kives S, Hahn PM, Reid RL. What women believe about oral contraceptives and the effect of counseling? Contraception 2004; 69; 31-36.

Reid RL. Double Jeopardy: Hormone Therapy on Trial Again (Guest Editorial). JOGC 2004:26(6): 541-543.

Davis V, Hauck B, Dunn S, Jamieson MA, Lea R, Lemieux L, Reid R, Senikas V, Guilbert E and the Canadian Mircette Study Group. An open label, multicenter, randomized, comparative safety and efficacy, cycle control, and quality of life study of CTR 25 (Mircette), Alesse, and Ortho Tricyclen. Research Papers in Fertility and Reproductive Medicine, International Congress Series 1271, Elsevier 2004 307-310

Utian WH, Archer DF, Gallagher JC, Gass MLS, Gelfand MM, Henderson VW, Hodis HN, Lobo RA, McClung M, Reid RL, Schwartz PE, Stefanick ML, Woods NF. Recommendations for estrogen and progestogens use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society; Menopause 2004;11(6):589-600

Kives S, Hahn PM, White E, Stanczyk F, Reid RL. Bioavailability of the Yuzpe and levonorgestrel regimens of emergency contraception: vaginal versus oral administration. Contraception 2005;71(3):197-201.

Lujan ME. Krzemien AA. Reid RL. Van Vugt DA. Caloric restriction inhibits steroid-induced gonadotropin surges in ovariectomized rhesus monkeys. Endocrine 2005; 27(1):25-31

Collins J, Crosignani PG, and the ESHRE Capri Working Group (R L Reid,  Member and author of PMS section). Non Contraceptive Health Benefits of Combined Oral contraception. Human Reprod Update 2005; 11(5):513-525

Steiner M, Macdougall M, Berger C, Carter D, Reid RL, Steinberg S,Stewart D. Assessment of sexual drive and desire in women with premenstrual dysphoric disorder who have been treated with fluoxetine. Internat J Psychiatry Clin Pract        2005; 9(2): 120-123

Mor E, Saadat P, Kives S, Mamikunian G, White E, Reid RL, Paulson RJ, Stanczyk F. Comparison of Vaginal and Oral Administration of Emergency Contraception: Circulating Gonadotropin, Globulin, and Androgen Levels Fertil            Steril 2005;84:40-45

Lea RH, Provencher DM, Jeffrey JF, Oza A, Reid RL, Swenerton KD. Breast cancer and abortion. JOGC 2005; 27(5):491

Lujan ME, Krzemien A, Reid RL, VanVugt DA. Developing a model of nutritional amenorrhea in Rhesus monkeys. Endocrinology 2006; 147 (1):483- 492

Fortier AM, Hahn PM, Trueman J, Reid RL. The acceptance of medical students by women with gynaecology appointments. JOGC 2006; 28(6):526- 530

Belisle S, Blake J, Basson R, Desindes S, Graves G, Grigoriadis S, Johnston S, Lalonde A, Mills C, Nash L, Reid R, Rowe T, Senikas V, Turek M. Canadian        Consensus Conference on Menopause: 2006 Update. JOGC 2006; Suppl 171: S1-112

Black A, Dunn S, Guilbert E, Leger F, Mirosh M, Reid R, Josse R, Lalonde A, SenikasV. Canadian Contraception Consensus—Update on Depot Medroxyprogesterone Acetate (DMPA) JOGC 2006; 174:305-308

McNaught J, Reid RL Progestin Only and non-hormonal contraception in the breast cancer survivor. Joint review and Committee opinion of SOGC and GOC. JOGC 2006; 28(7): 616- 626

Van Vugt DA, Lujan ME, Froats M, Krzemien A, Couceyro PR , Reid RL. Effect of Fasting on Cocaine- Amphetamine-Regulated Transcript, Neuropeptide Y, and Leptin Receptor Expression in the Non-Human Primate Hypothalamus. Neuroendocrinol 2006; 84(2):83-93

Lujan ME, Krzemien AA, Reid RL, Van Vugt DA. Effect of Leptin Administration on Ovulation in Food-Restricted Rhesus Monkeys.  Neuroendocrinol 2006; 84(2):103-114

Reid RL (Editorial) Hormonal contraception and breast cancer: Keeping perspective. JOGC 2007; 29(3): 207-209

Reid RL. Invited Commentary: Hormone therapy for younger women may not increase CHD risk during 5-7 years of follow-up, but stroke risk was increased independent of age. American College of Physicians Journal Club 2007; 147(2):29

Utian WH, Archer DF, Bachmann GA, Reid RL, and other Advisory Board Members. Estrogen and progestogens use in the peri-and postmenopausal women: March 2007 position statement of the North American Menopause Society. Menopause 2007; 14(2): 168-182

Reid RL. Patient Safety. Canadian Consensus Conference on Continuous Hormonal Contraception. JOGC 2007;29(7) Suppl 2: S19-S24

Srikanthan A, Reid RL. Contraception utilization and adherence: religious and cultural influences. JOGC 2008; 30(2):129-37

Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA. North American Menopause Society. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008; 15(4 Pt 1):584-602

Racz JM, Srikanthan A, Hahn PM, Reid RL. Gender preference for a female physician diminishes as women have increased experience with intimate examinations. JOGC 2008; 30(10): 910-917

Shapiro H, Reid RL, Rowe T. World anti Doping Agency (WADA) Medical Information to Support the Decisions of TUECs: Infertility. Accessed on Jan 23, 2009 at…

Reid RL, Blake J, Khan A, Fortier M, Senikas V. SOGC Consensus Document on Menopause and Osteoporosis 2009; JOGC 2009; 31(1) Suppl 1: S1-S48 [CPG 222]

Reid RL. Editorial. Hormone therapy: rigour and responsibility in knowledge translation. JOGC 2009; 31(1): 13-15

Reid RL. Non-contraceptive uses of hormonal contraceptives. ACOG Clinical Practice Guideline No 110. Obstet Gynecol 2010; 115(1):206-218

Utian W, Reid RL et al. Estrogen and progestogen use in postmenopausal women: 2010 Position Statement of The North American Menopause Society. Menopause 2010; 17(2):242-255

Reid RL, Westhoff C, Mansour D, de Vries C, Verhaeghe J, Boschitsch E, Gompel A, Birkhäuser M, Krepelka P, Dulicek P, Iversen O-E, Khamoshina M, Vrabic Dezman L, Fruzzetti F, Szarewski A, Wilken-Jensen C, Seidman D, Kaaja R, Shapiro S. Oral Contraceptives and Venous Thromboembolism Consensus Opinion from an International Workshop held in Berlin, Germany in December 2009. J Fam Plann Reprod Health Care 2010; 36(3):117-122

Reid RL, Fortier MP, Mirkin S, Grubb GS, Constantine GD. Safety and bleeding profile of continuous levonorgestrel 90 ug/ ethinyl estradiol 20 ug based on 2 years of clinical trial data in Canada. Contraception 2010;82(6):497-502.

Reid RL and the Clinical Practice Gynecology Committee of SOGC. Oral contraceptives and the risk of venous thromboembolism: An update. SOGC Clinical Practice Guideline 252; JOGC 2010; 32(12): 1192-1197

Reid RL. Confusion about Hormone Therapy: Misinterpretation of the Findings of the Women’s Health Initiative. Canadian Pharmacists Journal 2010; 143 [Suppl 2]: S7-S8

O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson E, Freeman E, Halbreich U, Ismail KM, Panay N. Pearlstein T, Rapkin A, Reid RL, Schmidt O, Steiner M, Studd J, Yonkers K. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women's Mental Health 2011; 14(1):13-21

Levy AR, Osenenko K, Lozano-Ortega G, Sambrook R, Jeddi M, Belisle S, Reid RL. Economic burden of surgically-confirmed endometriosis in Canada. J.Obstet Gynaecol Can 2011; 33(8):830

Reid RL. Oral Contraceptives and Venous Thromboembolism: Pill Scares and Public Health. JOGC 2011; 33(11):1150-1155

Ronn R, Smith W, Magee B, Hahn PM, Reid RL. Can online learning adequately prepare medical students to undertake a first female pelvic examination? JOGC 2012; 34(3):264-8

Gemzell-Danielsson K, Cho SH, Inki P, Mansour D, Reid R, Bahamondes L. Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling —results of an international survey in 10 countries. Contraception 2012: 86: 631-638

Waddington A, Reid RL. More harm than good: the lack of evidence for administering misoprostol prior to IUD insertion. JOGC 2012;34 (12): 1177-1179

Reid RL. When should surgical treatment for Premenstrual Dysphoric Disorder be considered? Premenstrual disorders. Menopause International 2012; 18(2):77-81

O’Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, Epperson E, Freeman E, Halbreich U, Ismail KM, Panay N. Pearlstein T, Rapkin A, Reid RL, Schmidt O, Steiner M, Studd J, Yonkers K. ISPMD Consensus on the management of premenstrual disorders. Arch Women’s Mental Health 2013; 16(4):279-291

Van Vugt DA, Krzemien A, Alsaadi H, Palerme S, Reid RL. Effect of insulin sensitivity on corticolimbic responses to food picture in women with polycystic ovary syndrome. Obesity (Silver Spring). 2013; 21:1215-22.

Reid RL. Invited Commentary in Obstetrics and Gynecology Management: Stop: enforcing a 5-year rule for estrogen therapy for menopausal symptoms.Start: individualizing therapy to optimize health and QOL. Ob/Gyn Management 2013; 25(12):24-28

Khosravi F, Reid RL, Moini A, Abolhassani F, Kan FWK. In vitro development of human primordial follicles to preantral stage after vitrification. J Assist Reprod Genetics 2013; 30:1397–1406

Reid R L. Oral Hormonal contraception and venous thromboembolism. Contraception 2014; 89:235–236

VanVugt DA, Krzemien A, Alsaadi H, Frank TC, Reid RL. Glucose-induced inhibition of the appetitive brain response to visual food cues in polycystic ovary syndrome patients. Brain Research (2014),

Reid RL. ‘Menopausal hormone therapy and breast cancer’. Chapter 3 in Managing menopause. An SOGC Clinical Practice Guideline No 311 September 2014;36 (9 eSuppl A):S23-30

Reid RL ‘Vasomotor symptoms’. Chapter 4 in Managing menopause. An SOGC Clinical Practice Guideline No 311 September 2014;36 (9 eSuppl A):S31-34

Reid RL, Fortier M. Menopausal Hormone Therapy and Quality of life: Too many pyjamas. JOGC 2014; 36: 953-954

Waddington A, Hahn PM, Reid RL. Determinants of late presentation for induced abortion care. JOGC 37(1): 40-46

All Departmental Publications